Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study.
Yao T, Lu W, Ke J, Zhang H, Zhao X, Song B, Liu T, Ke Q, Liu C.
Front Endocrinol (Lausanne). 2022 Apr 20;13:865863. doi: 10.3389/fendo.2022.865863. eCollection 2022.
PMID:35573992
The value of exercise in preventing coronary atherosclerotic heart disease.
Fletcher GF.
Heart Dis Stroke. 1993 May-Jun;2(3):183-7.
PMID:8137023
Cardio-renal interaction in coronary artery disease.
Ishii H.
Int J Cardiol. 2023 Apr 15;377:17-18. doi: 10.1016/j.ijcard.2023.01.008. Epub 2023 Jan 11.
PMID:36640959
Atherosclerotic Heart Disease in Women With Autoimmune Rheumatologic Inflammatory Conditions.
Kurmann RD, Mankad R.
Can J Cardiol. 2018 Apr;34(4):381-389. doi: 10.1016/j.cjca.2018.01.015. Epub 2018 Jan 31.
PMID:29571422
The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C.
Jung HW, Ra M, Bae HJ, Hong SP.
Medicine (Baltimore). 2023 Jan 6;102(1):e32596. doi: 10.1097/MD.0000000000032596.
PMID:36607865
Proteomics analysis of coronary atherosclerotic heart disease with different Traditional Chinese Medicine syndrome types before and after percutaneous coronary intervention.
Zhibo W, Ying LI, Daoping W, Bo MA, Lan M, Junguo R, Jinghua L, Jianxun L.